Lincoln Pharmaceuticals Ltd's total assets for Q4 2025 were ₹7.97B, an increase of Infinity% from the previous quarter. IN:LINCOLN total liabilities were ₹1.25B for the fiscal quarter, a -119.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.